Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure

Dustin Ruff(Eli Lilly (United States)), Sheena K. Aurora(Impel Neuropharma (United States)), Matthew G. Sexson(Eli Lilly (United States)), Shuu‐Jiun Wang(National Yang Ming Chiao Tung University), Eric Pearlman(University of California, San Francisco), Sriram Govindan(Eli Lilly (India)), Arif Khan(Duke University), Antje Tockhorn‐Heidenreich(Eli Lilly (United States)), Janet H. Ford(Agios Pharmaceuticals (United States))
Cephalalgia
May 19, 2019
10.1177/0333102419847957
Cited by 41

Related Papers

Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
|Pain|2018|3.2k
A classification of chronic pain for ICD-11
|Pain|2015|2.8k
The IASP classification of chronic pain for ICD-11: chronic primary pain
|Pain|2018|1.3k
The IASP classification of chronic pain for ICD-11: chronic neuropathic pain
|Pain|2018|1.1k
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532